Skip to main content
Article thumbnail
Location of Repository

Analysis of NCL Proteins from an Evolutionary Standpoint

By Neda E Muzaffar and David A Pearce

Abstract

The Neuronal Ceroid Lipofuscinoses (NCLs) are the most common group of neurodegenerative disorders of childhood. While mutations in eight different genes have been shown to be responsible for these clinically distinct types of NCL, the NCLs share many clinical and pathological similarities. We have conducted an exhaustive Basic Local Alignment Search Tool (BLAST) analysis of the human protein sequences for each of the eight known NCL proteins- CLN1, CLN2, CLN3, CLN5, CLN6, CLN7, CLN8 and CLN10. The number of homologous species per CLN-protein identified by BLAST searches varies depending on the parameters set for the BLAST search. For example, a lower threshold is able to pull up more homologous sequences whereas a higher threshold decreases this number. Nevertheless, the clade confines are consistent despite this variation in BLAST searching parameters. Further phylogenetic analyses on the appearance of NCL proteins through evolution reveals a different time line for the appearance of the CLN-proteins. Moreover, divergence of each protein shows a different pattern, providing important clues on the evolving role of these proteins. We present and review in-depth bioinformatic analysis of the NCL proteins and classify the CLN-proteins into families based on their structures and evolutionary relationships, respectively. Based on these analyses, we have grouped the CLN-proteins into common clades indicating a common evolving pathway within the evolutionary tree of life. CLN2 is grouped in Eubacteria, CLN1 and CLN10 in Viridiplantae, CLN3 in Fungi/ Metazoa, CLN7 in Bilateria and CLN5, CLN6 and CLN8 in Euteleostomi

Topics: Article
Publisher: Bentham Science Publishers Ltd.
OAI identifier: oai:pubmedcentral.nih.gov:2674804
Provided by: PubMed Central
Download PDF:
Sorry, we are unable to provide the full text but you may find it at the following location(s):
  • http://www.pubmedcentral.nih.g... (external link)
  • Suggested articles

    Citations

    1. (2002). [Baker's cysts in patients with gonarthrosis in early stages according to arthrosonography and magnetic resonance tomography].
    2. (2002). [Tripeptidyl peptidase 1 deficiency in neuronal ceroid lipofuscinosis. A novel mutation].
    3. (2005). A clinical rating scale for Batten disease: reliable and relevant for clinical trials. Neurology
    4. (1999). A lysosomal proteinase, the late infantile neuronal ceroid lipofuscinosis gene (CLN2) product, is essential for degradation of a hydrophobic protein, the subunit c of ATP synthase.
    5. (2000). A mutation in the ovine cathepsin D gene causes a congenital lysosomal storage disease with profound neurodegeneration.
    6. (1999). A new locus for variant late infantile neuronal ceroid lipofuscinosis-CLN7.
    7. (1999). A new simple enzyme assay for pre- and postnatal diagnosis of infantile neuronal ceroid lipofuscinosis (INCL) and its
    8. (1999). A rapid fluorogenic palmitoyl-protein thioesterase assay: pre- and postnatal diagnosis of INCL.
    9. (1954). A second case in the same family of congenital familial cerebral lipoidosis resembling amaurotic family idiocy.
    10. (1982). A variant of Jansky-Bielschowsky disease.
    11. (1999). Action of BTN1, the yeast orthologue of the gene mutated in
    12. (2001). Adult neuronal ceroid lipofuscinosis with palmitoylprotein thioesterase deficiency: first adult-onset patients of a childhood disease.
    13. (2001). Altered levels of high-energy phosphate compounds in fibroblasts from different forms of neuronal ceroid lipofuscinoses: further evidence for mitochondrial involvement.
    14. (1999). Analysis of intracellular distribution and trafficking of the CLN3 protein in fusion with the green fluorescent protein in vitro.
    15. (1997). Association of mutations in a lysosomal protein with classical late-infantile neuronal ceroid lipofuscinosis. Science
    16. (2000). Batten disease: evaluation of CLN3 mutations on protein localization and function.
    17. (1998). Beyond complete genomes: from sequence to structure and function.
    18. (2001). Biochemical analysis of mutations in palmitoyl-protein thioesterase causing infantile and late-onset forms of neuronal ceroid lipofuscinosis.
    19. (1998). Biosynthesis and intracellular targeting of the CLN3 protein defective in Batten disease.
    20. (2003). Biosynthesis, glycosylation, and enzymatic processing in vivo of human tripeptidyl-peptidase
    21. Catalytic residues and substrate specificity of recombinant human tripeptidyl peptidase I
    22. (2000). Cathepsin D deficiency induces lysosomal storage with ceroid lipofuscin in mouse CNS neurons.
    23. (2006). Cathepsin D deficiency is associated with a human neurodegenerative disorder.
    24. (2006). Cathepsin D deficiency underlies congenital human neuronal ceroid-lipofuscinosis. Brain
    25. (2005). Cathepsin D-deficient Drosophila recapitulate the key features of neuronal ceroid lipofuscinoses.
    26. (2001). Cellular pathology and pathogenic aspects of neuronal ceroid lipofuscinoses.
    27. (1989). Ceroid-lipofuscinosis (Batten's disease): pathogenesis and sequential neuropathological changes in the ovine model.
    28. (2000). Characterization of endopeptidase activity of tripeptidyl peptidase-I/CLN2 protein which is deficient in classical late infantile neuronal ceroid lipofuscinosis.
    29. (1998). Chromosomal localization of two genes underlying late-infantile neuronal ceroid lipofuscinosis. Neurogenetics
    30. (1999). Classical late infantile neuronal ceroid lipofuscinosis fibroblasts are deficient in lysosomal tripeptidyl peptidase I. FEBS Lett.
    31. (1999). CLN3 defines a novel antiapoptotic pathway operative in neurodegeneration and mediated by ceramide.
    32. (1998). CLN5, a novel gene encoding a putative transmembrane protein mutated in Finnish variant late infantile neuronal ceroid lipofuscinosis.
    33. (2004). CLN6, which is associated with a lysosomal storage disease, is an endoplasmic reticulum protein. Exp. Cell Res.
    34. (1985). Cloning and sequence analysis of cDNA for human cathepsin D.
    35. (1985). Congenital amaurotic idiocy--a pathological, histochemical, biochemical and ultrastructural study.
    36. Congenital amaurotic idiocy.
    37. (1992). Congenital ceroidlipofuscinosis.
    38. Congenital form of amaurotic family idiocy.
    39. (2004). Defective endoplasmic reticulum-resident membrane protein CLN6 affects lysosomal degradation of endocytosed arylsulfatase
    40. (1999). Defective intracellular transport of CLN3 is the molecular basis of Batten disease
    41. (2006). Diagnosis of the neuronal ceroid lipofuscinoses: an update.
    42. (2001). Elevated lysosomal pH in neuronal ceroid lipofuscinoses (NCLs).
    43. (2004). Evaluation of 36 patients from Turkey with neuronal ceroid lipofuscinosis: clinical, neurophysiological, neuroradiological and histopathologic studies. Turk
    44. (1992). Evidence for lipase abnormality: high levels of free and triacylglycerol forms of unsaturated fatty acids in neuronal ceroid-lipofuscinosis tissue.
    45. (1995). Families of aspartic peptidases, and those of unknown catalytic mechanism. Methods Enzymol.
    46. (1999). First-trimester diagnosis of infantile neuronal ceroid lipofuscinosis (INCL) using PPT enzyme assay and CLN1 mutation analysis.
    47. (2006). Functional biology of the neuronal ceroid lipofuscinoses (NCL) proteins.
    48. Gene table: neuronal ceroid lipofuscinoses.
    49. (1997). Genomic structure and complete nucleotide sequence of the Batten disease gene, CLN3. Genomics
    50. (1992). Human liver cathepsin D. Purification, crystallization and preliminary X-ray diffraction analysis of a lysosomal enzyme.
    51. (1996). Human palmitoyl protein thioesterase: evidence for lysosomal targeting of the enzyme and disturbed cellular routing in infantile neuronal ceroid lipofuscinosis.
    52. (1991). Infantile form of neuronal ceroid lipofuscinosis (CLN1) maps to the short arm of chromosome 1. Genomics
    53. (1974). Infantile type of so-called neuronal ceroid-lipofuscinosis.
    54. (1973). Infantile type of socalled neuronal ceroid-lipofuscinosis. 1. A clinical study of 15 patients.
    55. (2002). LAG1 and CLN8: members of a novel family of lipid-sensing domains? Trends Biochem. Sci.
    56. (1996). Lipid thioesters derived from acylated proteins accumulate in infantile neuronal ceroid lipofuscinosis: correction of the defect in lymphoblasts by recombinant palmitoyl-protein thioesterase.
    57. (1997). Loci for classical and a variant late infantile neuronal ceroid lipofuscinosis map to chromosomes 11p15 and 15q21-23.
    58. (2002). Luminescence excitation spectra reveal low-lying excited states in stacked adenine bases.
    59. (2002). Lysosomal localization of the neuronal ceroid lipofuscinosis CLN5 protein.
    60. (1996). Lysosomal targeting of palmitoyl-protein thioesterase.
    61. (1999). Mechanisms and kinetics of procathepsin D activation.
    62. (2003). Membrane topology of CLN3, the protein underlying Batten disease. FEBS Lett.
    63. (1992). Mitochondrial ATP synthase subunit c storage in the ceroidlipofuscinoses (Batten disease).
    64. (1994). Molecular cloning and expression of palmitoylprotein thioesterase.
    65. (1999). Molecular genetics of the neuronal ceroid lipofuscinoses. Epilepsia
    66. (2002). Motifs within the CLN3 protein: modulation of cell growth rates and apoptosis.
    67. (2002). Mutations in a novel CLN6-encoded transmembrane protein cause variant neuronal ceroid lipofuscinosis in
    68. (2004). Mutations in classical late infantile neuronal ceroid lipofuscinosis disrupt transport of tripeptidyl-peptidase I to lysosomes.
    69. (1995). Mutations in the palmitoyl protein thioesterase gene causing infantile neuronal ceroid lipofuscinosis. Nature
    70. (1996). Neurology of hereditary metabolic diseases of children,
    71. (2002). Neuronal ceroid lipofuscinoses are connected at molecular level: interaction of
    72. (2001). Neuronal ceroid lipofuscinoses: classification and diagnosis.
    73. (2008). Neuronal ceroid lipofuscinoses: research update.
    74. (2005). Neuronal ceroid-lipofuscinoses. Gene Reviews at http://www.genetests.org.
    75. (1969). Neuronal ceroid-lipofuscinosis (Batten's disease): relationship to amaurotic family idiocy? Pediatrics
    76. (1995). New insight into lysosomal protein storage disease: delayed catabolism of ATP synthase subunit c in Batten disease.
    77. (2001). New mutations in the neuronal ceroid lipofuscinosis genes.
    78. (2005). Novel CLN3 mutation predicted to cause complete loss of protein function does not modify the classical JNCL phenotype.
    79. (2005). Palmitoyl Protein Thioesterase1 (PPT1) and Tripeptidyl Peptidase-I (TPP-I) are expressed in the human saliva. A reliable and non-invasive source for the diagnosis of infantile (CLN1) and late infantile (CLN2) neuronal ceroid lipofuscinoses.
    80. (1985). Partial purification and characterization of an ovarian tripeptidyl peptidase: a lysosomal exopeptidase that sequentially releases collagenrelated (Gly-Pro-X) triplets.
    81. (2000). Phenotypegenotype correlation in eight patients with Finnish variant late infantile NCL (CLN5). Neurology
    82. (2001). Positional candidate gene cloning of CLN1.
    83. (1999). Progress toward the cloning of CLN6, the gene underlying a variant LINCL.
    84. (1996). Protein sequence comparison at genome scale. Methods Enzymol.
    85. (1998). Purification and characterisation of a tripeptidyl aminopeptidase I from rat spleen.
    86. (1993). Purification and characterization of a tripeptidyl peptidase I from human osteoclastomas: evidence for its role in bone resorption.
    87. (1993). Purification and properties of a palmitoyl-protein thioesterase that cleaves palmitate from H-Ras.
    88. (1989). purification, and active site mutagenesis of recombinant porcine pepsinogen.
    89. (2003). Spectrum of CLN6 mutations in variant late infantile neuronal ceroid lipofuscinosis.
    90. (1995). Sphingolipid activator proteins (SAPs) are stored together with glyglycosphingolipids in the infantile neuronal ceroid-lipofuscinosis
    91. (1993). Storage of saposins A and D in infantile neuronal ceroid-lipofuscinosis. FEBS Lett.
    92. (1998). Structural organization and sequence of CLN2, the defective gene in classical late infantile neuronal ceroid lipofuscinosis. Genomics
    93. (1997). Structure of the CLN3 gene and predicted structure, location and function of CLN3 protein. Neuropediatrics
    94. (2001). Studies of homogenous populations:
    95. (2000). The crystal structure of palmitoyl protein thioesterase 1 and the molecular basis of infantile neuronal ceroid lipofuscinosis.
    96. (2002). The gene mutated in variant late-infantile neuronal ceroid lipofuscinosis (CLN6) and in nclf mutant mice encodes a novel predicted transmembrane
    97. (2001). The human CLN2 protein/tripeptidyl-peptidase I is a serine protease that autoactivates at acidic pH.
    98. (1960). The isolation and properties of a proteolytic enzyme, cathepsin D, from bovine spleen.
    99. (1999). The molecular basis of GROD-storing neuronal ceroid lipofuscinoses in
    100. (1999). The neuronal ceroid lipofuscinoses (Batten disease).
    101. (1999). The neuronal ceroid lipofuscinoses in human EPMR and mnd mutant mice are associated with mutations in CLN8.
    102. (2002). The neuronal ceroid lipofuscinoses: mutations in different proteins result in similar disease. Neuromol Med.
    103. (2005). The neuronal ceroid lipofuscinosis Cln8 gene expression is developmentally regulated in mouse brain and upregulated in the hippocampal kindling model of epilepsy.
    104. (2007). The novel neuronal ceroid lipofuscinosis gene MFSD8 encodes a putative lysosomal transporter.
    105. (2000). The Sec61p complex mediates the integration of a membrane protein by allowing lipid partitioning of the transmembrane domain. Cell
    106. (1991). The spectrum of JanskyBielschowsky disease. Neuropediatrics
    107. (2008). The yeast model for Batten disease: a role for Btn2p in the trafficking of the Golgiassociated vesicular targeting protein,
    108. The yeast model for batten disease: mutations in BTN1, BTN2, and HSP30 alter pH homeostasis.
    109. (2006). Thematic review series: lipid posttranslational modifications. Lysosomal metabolism of lipid-modified proteins.
    110. (1998). TRAM regulates the exposure of nascent secretory proteins to the cytosol during translocation into the endoplasmic reticulum. Cell
    111. (1999). Tripeptidyl-peptidase I is apparently the CLN2 protein absent in classical late-infantile neuronal ceroid lipofuscinosis.
    112. (2001). Turkish variant late infantile neuronal ceroid lipofuscinosis (CLN7) may be allelic to CLN8.
    113. (1993). Two crystal structures for cathepsin D: the lysosomal targeting signal and active site.
    114. (1999). Two endoplasmic reticulum (ER) membrane proteins that facilitate ER-to-Golgi transport of glycosylphosphatidylinositol-anchored proteins.
    115. (2005). Two novel CLN6 mutations in variant late-infantile neuronal ceroid lipofuscinosis patients of Turkish origin.
    116. (2004). Variant late infantile neuronal ceroid lipofuscinosis in a subset of Turkish patients is allelic to
    117. (1997). Variant late infantile neuronal ceroid-lipofuscinosis: pathology and biochemistry.

    To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.